FGF21 and obesity due to melanocortin 4 receptor deficiency: In animal studies, it was also found that the administration of FGF21 to mice with high-fat diet-induced obesity reduces their body weight by increasing energy expenditure and reducing glycemia, and leads to the reduction of hepatic steatosis [12].